BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-4584

  1. 1,758 Posts.
    lightbulb Created with Sketch. 1162
    Yeah, but limited availability for some reason. Why? Is it subject to ongoing scrutiny from the FDA or something? Why call it a 'De Novo' request - that's obviously different to a full throated application approval from the FDA for a new drug. "De Novo's" seem to be for a new 'device', so perhaps there is nothing new in the chemical being used, just how it is being applied? Also, they don't share cost/price on their website (I wouldn't expect them to) - but I wonder what a treatment would cost?
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.